Bluefin Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Bluefin Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30,530	Closed	-$304K	–	124
2025 Q2	$304K	Buy	+30,530	New	+$246K	0.23%	68

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bluefin Capital Management's ITOS Position: Q3 2025 in Review

Bluefin Capital Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 30,530 shares — an estimated $304K sold.

Bluefin Capital Management first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $304K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Bluefin Capital Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Bluefin Capital Management sold 30,530 iTeos Therapeutics shares in Q3 2025, an estimated $304K.
Bluefin Capital Management first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Bluefin Capital Management's iTeos Therapeutics position peaked at $304K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Bluefin Capital Management's 13F filing for Q3 2025, filed 29 Apr 2026.